Home/Nektar Therapeutics/Howard W. Robin
HW

Howard W. Robin

President & Chief Executive Officer

Nektar Therapeutics

Nektar Therapeutics Pipeline

DrugIndicationPhase
RezpegaldesleukinAtopic DermatitisPhase 2b
NKTR-0165Ulcerative Colitis, Vitiligo, Multiple SclerosisPreclinical